诚信认证:
工商注册信息已核实!
快速导航
产品分类
微信二维码
Minisite
激酶
TAK-285
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
货号 | CAS号 | 操作 |
---|---|---|
T126234-10mg | 871026-44-7 | 询价 |
T126234-1mg | 871026-44-7 | 询价 |
T126234-50mg | 871026-44-7 | 询价 |
T126234-5mg | 871026-44-7 | 询价 |
产品介绍
- 分子式 C26H25ClF3N5O3
- 分子量547.96
属性
溶解性 |
|
存贮条件 | 储存温度-20°C |
描述
备注 | TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. Phase 1. |
生化机理 |
TAK-285 is a novel dual HER2 and EGFR inhibitor with IC50 of 17 nM and 23 nM, respectively. A Phase I study of TAK-285 in patients with advanced cancer has been completed. TAK-285 is a novel, orally active, dual HER2/EGFR inhibitor with antitumor activity in mouse xenograft models, including breast, gastric, lung, and colon cancer. |
别名 | N-(2-(4-(3-chloro-4-(3-(trifluoromethyl)phenoxy)phenylamino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide;N-(2-(4-(3-chloro-4-(3-(trifluoromethyl)phenoxy)phenylamino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide |
TAK-285信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于TAK-285报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途